(Q44474756)

3 December 2017

title

Novel anticoagulant polyethylenimine: inhibition of thrombin-catalyzed fibrin formation (English)

1 reference

3 December 2017

1 reference

1 reference

Arthur J Chu

1

1 reference

3 December 2017

Salwa Beydoun

series ordinal

2

1 reference

3 December 2017

Suresh T Mathews

series ordinal

3

1 reference

3 December 2017

Julie Hoang

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Archives of Biochemistry and Biophysics

3 December 2017

published in

1 reference

3 December 2017

volume

415

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

101-108

1 reference

Disseminated intravascular coagulation in sepsis

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Inflammation and thrombosis: the clot thickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Acquired antithrombin deficiency in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Peptide exosite inhibitors of factor VIIa as anticoagulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Coagulation factor Xa inhibition: biological background and rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Thrombin inhibitors as anticoagulant agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Direct thrombin inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Novel anticoagulant activity of polybrene: inhibition of monocytic tissue factor hypercoagulation following bacterial endotoxin induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Protamine inhibits tissue factor-initiated extrinsic coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Blockade by ruthenium red of tissue factor-initiated coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

High-performance anion-exchange chromatography of oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

GI pharmacology of polyethyleneimine I: effects on gastric emptying in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Carboxylic and Polyethyleneimine-Bound FAD Derivatives. Synthesis, Coenzymic Properties, Conformational and Enzyme-Coenzyme Interaction Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Poly(ethylenimine) and its role in gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Antimicrobial peptide buforin I inhibits tissue factor-initiated coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Annexin II tetramer inhibits plasmin-dependent fibrinolysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Regulation of plasmin activity by annexin II tetramer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Compound 48/80 suppresses monocytic tissue factor-initiated extrinsic blood coagulation induced by bacterial endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Thrombin functions during tissue factor-induced blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Mechanism of the anticoagulant action of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Tissue factor pathway inhibitor and the revised theory of coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Cell biology of tissue factor, the principal initiator of blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Tissue factor on the loose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Disseminated intravascular coagulation in trauma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

Possible role of Marcks in the cellular modulation of monocytic tissue factor-initiated hypercoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900216-9

10.1016/S0003-9861(03)00216-9

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference